News

Other news

Calypso Biotech BV secures 20 Million EUR in Series A Financing to Develop Anti-IL-15 Therapeutic Antibody for Autoimmune Diseases

By JLABS

Read full story
Other news

Johnson & Johnson Innovation Names Swedish Medical Technology Company PExA Awardee in the Carcinogenic Exposure Meter Quickfire Challenge

By JLABS

Read full story
Other news

Sirenas LLC. annouced today they have entered a muti-target research collaboration agreement with Bristol-Myers Squibb to deploy a drug discovery platform against undisclosed challenging therapeutic targets

By JLABS

Read full story
Other news

Nanovista Inc. closes $2.3 million seed round to advance its multimodal visualization agent towards clinical trials

By JLABS

Read full story
Other news

Symic Bio Completes the MODIFY2 Phase 2 Trial of SB-061 for the Treatment of Knee Osteoarthritis

By JLABS

Read full story
Other news

Imago BioSciences Receives FDA Approval of IND Application for the Treatment of Myeloid Malignancies

By JLABS

Read full story
Other news

Next stop, Europe! @JNJInnovation introduces @JLABS in Belgium

By JLABS

Read full story
Press release

Belgium-Based JLINX Incubator to Transition to Johnson & Johnson Innovation JLABS, Expanding Outreach Across Europe

By JLABS

Read full story
Other news

Advanced Proteome Therapeutics Corporation (APC), a therapeutics discovery and development company, and ImmunoBiochem Corporation, announced they are entering into a Collaboration and Option agreement to develop superior antibody-drug conjugates

By JLABS

Read full story
Other news

JLABS TMC Company finds Growth in Shrinking Cells

By JLABS

Read full story
Other news

With a potential cure for lysosomal storage disorders in hand, Avrobio raises $60M to back gene therapy pipeline

By JLABS

Read full story
Other news

Avrobio, announced they have completed a $60M Series B round to back their gene therapy pipeline

By JLABS

Read full story
Press release

Janssen Labs at San Diego Expands to Add Concept Lab and Open Collaboration Space to Accommodate Individual Entrepreneurs and Additional Life Science Start-Ups

By JLABS

Read full story